7 Thrombocytopenia Clinical Trials in Boston, MA (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Thrombocytopenia Studies in Boston

NCT06676904Recruiting

Neonatal Platelet Transfusion Threshold Trial

The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshol...

Boston, MANA2,433 participantsNICHD Neonatal Research Network

View Study Details

NCT04598750Recruiting

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as...

Boston, MA250 participantsKarolinska Institutet

View Study Details

NCT06948318Recruiting

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a condition where the immune system mistakenly destroys platelets, which are cells that help stop bleeding. This leads to a lower number of platelets, making i...

Boston, MAPHASE3150 participantsTakeda

View Study Details

NCT06817395Recruiting

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

Individuals with immune thrombocytopenia (ITP) frequently report difficulties with attention and memory. The main question this study seeks to answer is: Do patients with ITP have evidence of cogniti...

Boston, MA100 participantsMassachusetts General Hospital

View Study Details

NCT07007962Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

This is a multinational, open label, single arm study that will evaluate the impact of early multi-immune modulation with rilzabrutinib in adult ITP patients who failed first-line treatment. The study...

Boston, MAPHASE360 participantsSanofi

View Study Details

NCT07104565Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

This study will evaluate the safety and efficacy of tafasitamab in adult participants with primary autoimmune blood cell disorders....

Boston, MAPHASE256 participantsIncyte Corporation

View Study Details

NCT07095127Recruiting

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

The purpose of the study is to evaluate the safety of NVG-2089 and to evaluate how well patients respond to this investigational treatment. NVG-2089 is a new drug that is being developed for treating ...

Boston, MAPHASE230 participantsNuvig Therapeutics, Inc.

View Study Details

About Thrombocytopenia Clinical Trials in Boston

Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.

There are currently 7 thrombocytopenia clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 3,079 participants. Research is being sponsored by NICHD Neonatal Research Network, Karolinska Institutet, Takeda and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Thrombocytopenia Clinical Trials in Boston — FAQ

Are there thrombocytopenia clinical trials in Boston?

Yes, there are 7 thrombocytopenia clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What thrombocytopenia treatments are being tested?

The 7 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.

Data updated October 15, 2026 from ClinicalTrials.gov